Barbara Ryan
Investor Relations
Replay available
Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2020 Earnings Call
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) Q4 2020 earnings conference call, held 2021-03-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Greg Williams
Chief Executive Officer
Dr. Matthew Guderis
Vice President of Research
Stephen McDonald
Vice President of Finance and Accounting
Ted Tentoff
Analyst, Piper Sandler
Michelle Gilson
Analyst, Canaccord
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Eloxx Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.269 -- 00:00:04.311 webcast and conference call. Today's call is being recorded. 00:00:04.311 -- 00:00:09.333 At this time, I would like to turn the call over to Barbara Ryan, ELOX Investor Relations. 00:00:09.333 -- 00:00:11.554 Please begin. 00:00:11.554 -- 00:00:16.096 Thank you, Victor. Welcome and thank you for joining us this afternoon for a review of 00:00:16.096 -- 00:00:21.119 ELOX Pharmaceutical's fourth quarter and full year 2020 financial results 00:00:21.119 -- 00:00:24.280 and business update. Joining me this afternoon are Dr. 00:00:24.280 -- 00:00:29.682 Greg Williams, our Chief Executive Officer, Neil Beloff, Chief Operating Officer 00:00:29.682 -- 00:00:34.785 and General Counsel, Dr. Tom Haverty, our Chief Medical Officer, Dr. 00:00:34.785 -- 00:00:39.689 Matthew Guderis, Vice President of Research, and Stephen McDonald, our Vice President 00:00:39.689 -- 00:00:45.012 of Finance and Accounting. Before we begin, I would like to remind you that any statements 00:00:45.012 -- 00:00:49.696 made during this call that are not historical are considered to be forward-looking statements 00:00:49.696 -- 00:00:55.194 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:55.194 -- 00:01:00.058 Actual results may differ materially from those indicated by these statements as a result 00:01:00.058 -- 00:01:05.042 of various important factors, including those discussed in the risk factors section in 00:01:05.042 -- 00:01:10.125 our most recent annual report on Form 10-K, filed with the Securities and Exchange 00:01:10.125 -- 00:01:14.469 Commission, as well as our other reports filed with the SEC. 00:01:14.469 -- 00:01:19.072 Any forward-looking statements represent our views as of today, March 11, 2021 only. 00:01:19.072...